Why the study?
A classification system for infiltrative heart disease did not exist.
The MORAL-STAGE classification offers a comprehensive, ten-feature framework for categorizing infiltrative heart diseases, analogous to the MOGE(S) system for cardiomyopathies.
Answers are grounded in this paper and cite their sources.
Requires validation before clinical adoption; leaves open utility versus MOGE(S) in infiltrative diseases.
Infiltrative heart disease (InHD) is a group of diseases characterized by the deposition of abnormal substances in the heart tissue, causing diastolic, less often systolic, dysfunction of the ventricle(s). Their classification still does not exist. In 2013, the MOGE(S) classification of cardiomyopathies was published, taking into account, along with the morphological and functional characteristics of the heart, damage to other organs, the presence of genetic mutations, acquired causes (e.g., myocardial inflammation, autoimmune diseases, storage diseases, amyloidosis), etc. By analogy with it we offer the MORAL-STAGE classification for InHD. It includes ten features: morphofunctional characteristics (M), organ damage (O), risk of cardiac death (R), age of clinical presentation, age of disease-specific therapy initiation (A), localization of the infiltrative process (inside or outside the cell, L), information about the functional class heart failure and stage of infiltrative heart disease (S), treatment (T), abnormal rhythm or conduction (A), genetic or familial nature of inheritance (G), etiology of the process (E). This article summarizes the cornerstones of the MORAL-STAGE classification and its clinical relevance. In addition, new issues are discussed that can be considered in future versions of the MORAL-STAGE classification.
No takes yet. Share an insight, caveat, or question.
Резник et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: